Search research articles
Contact Us
Filters
Showing results (61-70 of 169) with videos related to
Page
of 17
Sort By:
Biochemistry
|
October 21, 1998
Crystal structure of 4-oxalocrotonate tautomerase inactivated by 2-oxo-3-pentynoate at 2.4 A resolution: analysis and implications for the mechanism of inactivation and catalysis
A B Taylor, R M Czerwinski, W H Johnson, et al.
Biochemistry
|
August 10, 2000
Mechanism of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor: properties of the P1G, P1A, Y95F, and N97A mutants
S L Stamps, A B Taylor, S C Wang, et al.
Biochemistry
|
May 1, 2001
The structural basis for the perturbed pKa of the catalytic base in 4-oxalocrotonate tautomerase: kinetic and structural effects of mutations of Phe-50
R M Czerwinski, T K Harris, M A Massiah, et al.
Biochemistry
|
October 2, 2007
Kinetic and stereochemical analysis of YwhB, a 4-oxalocrotonate tautomerase homologue in Bacillus subtilis: mechanistic implications for the YwhB- and 4-oxalocrotonate tautomerase-catalyzed reactions
Susan C Wang, William H Johnson, Robert M Czerwinski, et al.
Bioorganic Chemistry
|
November 16, 2010
Crystal structures of native and inactivated cis-3-chloroacrylic acid dehalogenase: Implications for the catalytic and inactivation mechanisms
Youzhong Guo, Hector Serrano, William H Johnson, et al.
Biochemistry
|
January 6, 2018
Inactivation of 4-Oxalocrotonate Tautomerase by 5-Halo-2-hydroxy-2,4-pentadienoates
Tyler M M Stack, Wenzong Li, William H Johnson, et al.
Bioorganic Chemistry
|
October 24, 2002
Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein
Nancy R Shine, Susan C Wang, Krystyna Konopka, et al.
Carcinogenesis
|
February 13, 2001
Oral administration of naturally occurring coumarins leads to altered phase I and II enzyme activities and reduced DNA adduct formation by polycyclic aromatic hydrocarbons in various tissues of SENCAR mice
H E Kleiner, S V Vulimiri, L Miller, et al.
Biochemistry
|
January 23, 1996
Catalytic role of the amino-terminal proline in 4-oxalocrotonate tautomerase: affinity labeling and heteronuclear NMR studies
J T Stivers, C Abeygunawardana, A S Mildvan, et al.
Topics in Health Information Management
|
April 8, 1993
Achieving empowerment through information
J C Parmalee, T O Scholomiti, P Whitman, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 169) with videos related to
Sort By:
Page
of 17
Biochemistry
|
October 21, 1998
Crystal structure of 4-oxalocrotonate tautomerase inactivated by 2-oxo-3-pentynoate at 2.4 A resolution: analysis and implications for the mechanism of inactivation and catalysis
A B Taylor, R M Czerwinski, W H Johnson, et al.
Biochemistry
|
August 10, 2000
Mechanism of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor: properties of the P1G, P1A, Y95F, and N97A mutants
S L Stamps, A B Taylor, S C Wang, et al.
Biochemistry
|
May 1, 2001
The structural basis for the perturbed pKa of the catalytic base in 4-oxalocrotonate tautomerase: kinetic and structural effects of mutations of Phe-50
R M Czerwinski, T K Harris, M A Massiah, et al.
Biochemistry
|
October 2, 2007
Kinetic and stereochemical analysis of YwhB, a 4-oxalocrotonate tautomerase homologue in Bacillus subtilis: mechanistic implications for the YwhB- and 4-oxalocrotonate tautomerase-catalyzed reactions
Susan C Wang, William H Johnson, Robert M Czerwinski, et al.
Bioorganic Chemistry
|
November 16, 2010
Crystal structures of native and inactivated cis-3-chloroacrylic acid dehalogenase: Implications for the catalytic and inactivation mechanisms
Youzhong Guo, Hector Serrano, William H Johnson, et al.
Biochemistry
|
January 6, 2018
Inactivation of 4-Oxalocrotonate Tautomerase by 5-Halo-2-hydroxy-2,4-pentadienoates
Tyler M M Stack, Wenzong Li, William H Johnson, et al.
Bioorganic Chemistry
|
October 24, 2002
Secretory leukocyte protease inhibitor: inhibition of human immunodeficiency virus-1 infection of monocytic THP-1 cells by a newly cloned protein
Nancy R Shine, Susan C Wang, Krystyna Konopka, et al.
Carcinogenesis
|
February 13, 2001
Oral administration of naturally occurring coumarins leads to altered phase I and II enzyme activities and reduced DNA adduct formation by polycyclic aromatic hydrocarbons in various tissues of SENCAR mice
H E Kleiner, S V Vulimiri, L Miller, et al.
Biochemistry
|
January 23, 1996
Catalytic role of the amino-terminal proline in 4-oxalocrotonate tautomerase: affinity labeling and heteronuclear NMR studies
J T Stivers, C Abeygunawardana, A S Mildvan, et al.
Topics in Health Information Management
|
April 8, 1993
Achieving empowerment through information
J C Parmalee, T O Scholomiti, P Whitman, et al.
Page
of 17